Besi Drugs Pvt. Ltd.
4 signals · 3 added · 1 dropped or cut · 0 intermediate projects
Plants in our filings
- Gat No. 200/1, Lakhmapur, Dindori, Nashik, Maharashtra
Signals
| Filing | Molecule | Signal | Stage | t / year | Source |
|---|---|---|---|---|---|
| Apr 2026 | Rivaroxaban | ↑ NEW AT SITE | Public hearing held | +6 | EIA executive summary, MPCB |
| Apr 2026 | Sitagliptin phosphate monohydrate | ↑ NEW AT SITE | Public hearing held | +3 | EIA executive summary, MPCB |
| Apr 2026 | Linagliptin | ↑ NEW AT SITE | Public hearing held | +3 | EIA executive summary, MPCB |
| Apr 2026 | Mefenamic acid | ↓ DROPPED | Public hearing held | −40 | EIA executive summary, MPCB |
Need an alternative supplier?
Find current manufacturers for any molecule, with US DMF and CEP status and contacts, in the api-fdf.com database.